Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Dilated Cardiomyopathy: A New Association?

Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) belongs to the most common immune-mediated chronic disorders of the peripheral nervous system and intravenous immunoglobulin is considered the first-line treatment. in addition to being characterized by numerous phenotypic variants, this condition has been described as associated with other pathologies that have an immune pathogenesis. We describe the clinical case of a patient in whom this condition we discovered was associated with the presence of dilated cardiomyopathy. We tried to be learned from this clinical case report the implications, as well as clinics, even pathogenetic both on the CIDP pathogenesis and on cell-mediated and humoral mechanisms act synergistically to cause damage to cardiac muscle, to be able to derive a therapeutic approach that was optimal.